Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease with Clinically Significant Fibrosis in Obese Patients with Type 2 Diabetes Mellitus — China, 2017–2024
1. 请及时下载文件确认是否正确, 系统将在 2026-11-02 16:59:33 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
文献链接: https://weekly.chinacdc.cn/en/article/doi/10.46234/ccdcw2025.248
其他信息:
出版社: Chinese Center for Disease Control and Prevention
作者: Chen Yuping; undefined undefined; Liang Xiao; Qi Yuxia; Liu Chuan; Dong Bingtian; Li Xia; Shen Jie; Zhou Xiqiao; Liang Xuan; Zheng Minghua; Li Huating; Wai-Sun Wong Vincent; M Younossi Zobair; Nan Yuemin; Qi Xiaolong; undefined undefined; undefined undefined; undefined undefined; undefined undefined; undefined undefined; undefined undefined; undefined undefined; undefined undefined; undefined undefined; undefined undefined; undefined undefined; undefined undefined
